↓ Skip to main content

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
4 X users
patent
2 patents
guideline
6 clinical guideline sources

Readers on

mendeley
211 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
Published in
Journal of Clinical Oncology, August 2013
DOI 10.1200/jco.2012.47.3009
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 211 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 <1%
Japan 1 <1%
Italy 1 <1%
United Kingdom 1 <1%
France 1 <1%
Germany 1 <1%
Unknown 205 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 38 18%
Student > Ph. D. Student 25 12%
Other 22 10%
Student > Doctoral Student 19 9%
Student > Bachelor 16 8%
Other 47 22%
Unknown 44 21%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 89 42%
Biochemistry, Genetics and Molecular Biology 22 10%
Agricultural and Biological Sciences 15 7%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Immunology and Microbiology 6 3%
Other 18 9%
Unknown 52 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2023.
All research outputs
#1,406,145
of 33,083,482 outputs
Outputs from Journal of Clinical Oncology
#3,793
of 30,598 outputs
Outputs of similar age
#10,137
of 236,275 outputs
Outputs of similar age from Journal of Clinical Oncology
#39
of 225 outputs
Altmetric has tracked 33,083,482 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 30,598 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.6. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,275 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 225 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.